Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Hypera S.A. (HYPMY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
8.03-0.06 (-0.74%)
At close: 03:50PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close8.09
Open8.02
Bid0.00 x 0
Ask0.00 x 0
Day's Range7.98 - 8.03
52 Week Range4.63 - 8.89
Volume1,922
Avg. Volume8,938
Market Cap5.083B
Beta (5Y Monthly)0.51
PE Ratio (TTM)16.06
EPS (TTM)0.50
Earnings DateN/A
Forward Dividend & Yield0.23 (2.86%)
Ex-Dividend DateJul 01, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for HYPMY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • HYPERA SA SPON ADR EA REPR 1 OR
    Analyst Report: Itaú Unibanco Holding S.A.Itaú Unibanco is the largest privately held bank in Brazil, the result of the 2008 merger between Banco Itaú and Unibanco. In addition to Brazil, the bank has significant operations in Chile, Colombia, Argentina, Uruguay, and Paraguay. Its commercial and consumer loans account for 36% of the bank’s total loans each, while foreign loans now account for 28% of the bank’s portfolio. Itaú also operates the fifth-largest insurer in Brazil and is the second-largest asset manager in the country, giving it broad reach over the Brazilian financial system.
    Rating
    Fair Value
    Economic Moat
    9 days agoMorningstar
View more
  • Reuters

    UPDATE 1-Brazilian drugmaker Hypera's talks with rivals not currently active, source says

    Brazilian pharmaceutical company Hypera has discussed a takeover offer from rival company NC Group, the owner of EMS SA, but talks are not currently active, one source with knowledge of the matter said on Wednesday. Hypera has also discussed a sale to local pharmaceutical company Eurofarma, the source added. Hypera's controlling shareholder, Joao Alves de Queiroz Filho, has a 21% stake in the company and a shareholder agreement with Mexican holding Maiorem SA de CV owns another 15%.

  • Reuters

    Brazilian drugmaker Hypera's talks with rivals not currently active -source

    Brazilian pharmaceutical company Hypera has discussed a takeover offer from rival company NC Group, the owner of EMS SA, but talks are not currently active, one source with knowledge of the matter said on Wednesday. Hypera has also discussed a sale to local pharmaceutical company Eurofarma, the source added. Hypera's controlling shareholder, Joao Alves de Queiroz Filho, has a 21% stake in the company and a shareholder agreement with Mexican holding Maiorem SA de CV owns another 15%.

  • Reuters

    Brazil's Hypera shares jump after leniency agreement with authorities

    Shares in Brazilian drugmaker Hypera SA rose 6% on Wednesday after it entered into a long-expected leniency agreement with the country's authorities related to investigations into illegal payments by former executives to public officials. The agreement, struck with Brazil's federal comptroller CGU and solicitor general AGU and announced on Tuesday, includes a fine of 110 million reais ($22.98 million), which will be paid by the company's founding shareholder Joao Alves de Queiroz Filho, with no cash impact for Hypera. JPMorgan analysts welcomed the agreement, saying it settled a long-term issue with the company's governance.

Advertisement
Advertisement